Phase II Trial of Fluorouracil (5-FU), Leucovorin (LV) [folinic acid], Irinotecan (CPT-11) and Bevacizumab (Anti-VEGF) in Previously Untreated Patients With Advanced Colorectal Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 24 Jun 2013 Biomarkers information updated
- 15 Sep 2005 New trial record.